| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 21,559 | 18,178 | 16,457 | 14,173 | | Cost of Revenue | 9,420 | 8,076 | 7,511 | 5,752 | | | Gross Profit | 12,139 | 10,102 | 8,946 | 8,421 | | | Operating Expenses | | Research Development | 7,550 | 8,570 | 7,903 | 6,802 | | Selling General and Administrative | 5,608 | 7,084 | 6,895 | 6,172 | | Non Recurring | 171 | 99 | 2,630 | 54,272 | | Others | 854 | 854 | 854 | 149 | | | | Total Operating Expenses | 14,183 | 16,607 | 18,282 | 67,395 | | | | Operating Income or Loss | (2,044) | (6,505) | (9,336) | (58,974) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (564) | (2,388) | (890) | 343 | | Earnings Before Interest And Taxes | (2,294) | (8,893) | (10,226) | (58,631) | | Interest Expense | (399) | 147 | 252 |
-
| | Income Before Tax | (1,895) | (9,040) | (10,478) | (58,631) | | Income Tax Expense | (41) | 16 | 19 | (316) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,854) | (9,056) | (10,497) | (58,315) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,854) | (9,056) | (10,497) | (58,315) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,854) | ($9,056) | ($10,497) | ($58,315) |
|
1.52% Nasdaq 0.00%
Income Statement
